Please enable JavaScript in your browser. 
Skip to main content
Drug Information Portal National Library of Medicine
       Home    Substance
1 result for Superlist ID equals S900006140
Drug Name: Cetuximab regimen with fluorouracil, irinotecan and Leucovorin View Structure
Description: A chemoimmunotherapy regimen consisting of leucovorin (folinic acid), 5-fluorouracil, and irinotecan plus cetuximab used for the treatment of metastatic colorectal cancer that is positive for the expression of the epidermal growth factor receptor (EGFR) and the wild-type form of KRAS. (NCI Thesaurus) Synonyms: FOLFIRI-Erbitux regimen leucovorin-fluorouracil-irinotecan-cetuximab regimen 

Site Map, Contact Us, Copyright, Privacy, Accessibility
U.S. National Library of Medicine, 8600 Rockville Pike, Bethesda, MD 20894
National Institutes of Health, Health & Human Services
Freedom of Information Act
Drug Information Portal Mobile Site
Last updated: Jun 2019